Cochlear Limited (ASX:COH – Get Free Report) insider Christine McLoughlin purchased 200 shares of the business’s stock in a transaction on Friday, February 28th. The stock was purchased at an average cost of A$261.73 ($164.61) per share, with a total value of A$52,346.00 ($32,922.01).
Cochlear Stock Performance
The company has a quick ratio of 1.93, a current ratio of 2.30 and a debt-to-equity ratio of 13.24. The stock has a market cap of $19.88 billion, a PE ratio of 55.90, a P/E/G ratio of 3.87 and a beta of 0.47.
Cochlear Increases Dividend
The firm also recently declared a Interim dividend, which will be paid on Sunday, April 13th. Shareholders of record on Sunday, April 13th will be issued a $2.15 dividend. This represents a yield of 0.78%. The ex-dividend date is Wednesday, March 19th. This is a positive change from Cochlear’s previous Interim dividend of $2.00. Cochlear’s payout ratio is 77.35%.
Cochlear Company Profile
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.
Recommended Stories
- Five stocks we like better than Cochlear
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- GitLab: Get In While It’s Down—Big Rebound Ahead
- There Are Different Types of Stock To Invest In
- Tesla Stock: Finding a Bottom May Take Time
- What Are Treasury Bonds?
- Duolingo: This Beaten-Down Stock Is About to Rally 38%
Receive News & Ratings for Cochlear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cochlear and related companies with MarketBeat.com's FREE daily email newsletter.
